NEXPOINT DIVERSIFIED REAL ES (NXDT)

US65340G2057 - REIT

6.36  +0.17 (+2.75%)

Fundamental Rating

2

Overall NXDT gets a fundamental rating of 2 out of 10. We evaluated NXDT against 126 industry peers in the Diversified REITs industry. NXDT has a bad profitability rating. Also its financial health evaluation is rather negative. NXDT does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

NXDT had negative earnings in the past year.
NXDT had a negative operating cash flow in the past year.
In multiple years NXDT reported negative net income over the last 5 years.
In multiple years NXDT reported negative operating cash flow during the last 5 years.

1.2 Ratios

NXDT has a worse Return On Assets (-11.09%) than 98.37% of its industry peers.
NXDT has a Return On Equity of -13.77%. This is amonst the worse of the industry: NXDT underperforms 89.43% of its industry peers.
NXDT has a Return On Invested Capital of 0.90%. This is amonst the worse of the industry: NXDT underperforms 84.55% of its industry peers.
NXDT had an Average Return On Invested Capital over the past 3 years of 4.58%. This is in line with the industry average of 2.95%.
Industry RankSector Rank
ROA -11.09%
ROE -13.77%
ROIC 0.9%
ROA(3y)5.28%
ROA(5y)1.31%
ROE(3y)5.05%
ROE(5y)1.33%
ROIC(3y)4.58%
ROIC(5y)3.43%

1.3 Margins

NXDT has a Operating Margin of 18.22%. This is comparable to the rest of the industry: NXDT outperforms 42.28% of its industry peers.
In the last couple of years the Operating Margin of NXDT has declined.
The Gross Margin of NXDT (78.28%) is better than 74.80% of its industry peers.
NXDT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.22%
PM (TTM) N/A
GM 78.28%
OM growth 3Y-26.58%
OM growth 5Y-19.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.51%
GM growth 5Y7.45%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NXDT is destroying value.
NXDT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXDT has more shares outstanding
NXDT has a worse debt/assets ratio than last year.

2.2 Solvency

NXDT has an Altman-Z score of 0.60. This is a bad value and indicates that NXDT is not financially healthy and even has some risk of bankruptcy.
NXDT has a Altman-Z score (0.60) which is in line with its industry peers.
A Debt/Equity ratio of 0.19 indicates that NXDT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.19, NXDT belongs to the top of the industry, outperforming 97.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 0.6
ROIC/WACC0.1
WACC8.92%

2.3 Liquidity

A Current Ratio of 1.02 indicates that NXDT should not have too much problems paying its short term obligations.
The Current ratio of NXDT (1.02) is worse than 60.16% of its industry peers.
NXDT has a Quick Ratio of 1.02. This is a normal value and indicates that NXDT is financially healthy and should not expect problems in meeting its short term obligations.
NXDT's Quick ratio of 1.02 is in line compared to the rest of the industry. NXDT outperforms 43.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02

1

3. Growth

3.1 Past

The earnings per share for NXDT have decreased strongly by -381.38% in the last year.
The Revenue for NXDT has decreased by -52.88% in the past year. This is quite bad
NXDT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.61% yearly.
EPS 1Y (TTM)-381.38%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q80.05%
Revenue 1Y (TTM)-52.88%
Revenue growth 3Y18.02%
Revenue growth 5Y9.61%
Revenue growth Q2Q-59.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXDT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NXDT indicates a slightly more expensive valuation: NXDT is more expensive than 65.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.28

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

NXDT has a Yearly Dividend Yield of 9.26%, which is a nice return.
Compared to an average industry Dividend Yield of 5.96, NXDT pays a better dividend. On top of this NXDT pays more dividend than 91.06% of the companies listed in the same industry.
NXDT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 9.26%

5.2 History

The dividend of NXDT decreases each year by -27.63%.
NXDT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-27.63%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of NXDT are negative and hence is the payout ratio. NXDT will probably not be able to sustain this dividend level.
DP-14.79%
EPS Next 2YN/A
EPS Next 3YN/A

NEXPOINT DIVERSIFIED REAL ES

NYSE:NXDT (4/18/2024, 10:51:19 AM)

6.36

+0.17 (+2.75%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap245.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 9.26%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.09%
ROE -13.77%
ROCE
ROIC
ROICexc
ROICexgc
OM 18.22%
PM (TTM) N/A
GM 78.28%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-381.38%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-52.88%
Revenue growth 3Y18.02%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y